CLAIRE SNODGRASS: Open Payments
NPI 1538811781 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,145 in 29 payments from 12 companies in 2025. Trend: 2023 $428 · 2024 $947 · 2025 $1,145
Food & beverage: $1,145
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $257 |
| AstraZeneca Pharmaceuticals LP | 8 | $256 |
| Dexcom, Inc. | 3 | $245 |
| RGH Enterprises LLC | 1 | $92 |
| Novo Nordisk Inc | 3 | $69 |
| ABBVIE INC. | 3 | $51 |
| Neurocrine BioSciences, Inc. | 1 | $49 |
| Exact Sciences Corporation | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: FREESTYLE LIBRE 3, DEXCOM G7 GSS (161), AIRSUPRA, BREZTRI, FREESTYLE LIBRE 2, Dexcom G6 Transmitter, INGREZZA, Cologuard Collection Kit.
Industry payments across AZ — which companies pay providers there.
